Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Peeps candy production halted ahead of Halloween due to pandemic

1Pink and yellow Marshmallow Peeps in Warminster, Pennsylvania. Photo: William Thomas Cain/Getty Images

There'll be no Peeps marshmallow candies produced for this Halloween — or Christmas or Valentine's Day either — because of the coronavirus pandemic, Just Born Quality Confections said, per Pennlive.com.

The big picture: The firm suspended production in two Pennsylvania facilities in March as the outbreak spread. Just Born resumed limited output in May, but said it won't make Peeps and other candies until next year to focus on meeting demand for next Easter. "We look forward to offering our fun seasonal shapes and packaging at all major seasons again beginning with Halloween of 2021," the company added.

Go deeper

Axios
Updated 10 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: The warning signs of a longer pandemic — CDC director: Answer to Michigan COVID-19 surge is "to close things down."
  2. Vaccines: FDA expects J&J vaccine pause to last "a matter of days" — Moderna says vaccines are over 90% effective 6 months after second shot — Pfizer says it can deliver 10% more vaccine doses to U.S. by end of May.
  3. Economy: Jobs growth could be curbed by demands for higher wages.
  4. States: New York to replace today's J&J vaccine appointments with Pfizer.
  5. World: Facebook to push notifications about vaccine eligibility to 20 countries outside of the U.S. — Brits flock to pubs for first time in months as U.K. lockdown eases.
  6. Variant tracker: Where different strains are spreading.
Go deeper (1 min. read)Arrow
Marisa Fernandez
Dec 21, 2020 - Health

The coronavirus mutation in the U.K.: What you need to know

Moncef Slaoui, chief science adviser for Operation Warp Speed. Photo: Mandel Ngan/AFP via Getty Images

Researchers are closely watching whether a newly discovered mutation in the SARS-CoV-2 virus is cause for alarm as parts of Europe limited international travel this week.

Why it matters: Despite the variant appearing to be more transmissible, U.S. officials stressed in a call today that it's no more deadly and the chances it will make vaccines less effective are "extremely low."

Go deeper (1 min. read)Arrow
Kadia Goba, Sarah Mucha
2 hours ago - Politics & Policy

Exclusive: White House meeting with members of Problem Solvers Caucus

Members of the Problem Solvers Caucus discuss the COVID-19 relief bill in December. Photo: Oliver Contreras/Bloomberg via Getty Images

Top White House officials will meet Wednesday with a bipartisan coalition of House lawmakers as the administration tries to enlist moderates to support the president's infrastructure proposal.

Why it matters: The meeting is something of an olive branch after President Biden's team courted groups of progressives to back the $2.2 trillion package.

Go deeper (1 min. read)Arrow